Crystal Arthritis

Study: Pegloticase & Methotrexate Co-Treatment Helps Uncontrolled Gout

January 10, 2022 • By Vanessa Caceres

Pegloticase Proves Promising for Gout in Patients who Have Undergone Kidney Transplant

December 8, 2021 • By Michele B. Kaufman, PharmD, BCGP

Gout, Imaging & Cardiovascular Disease: 2 Experts Discuss Challenging Patients & Advanced Imaging

November 23, 2021 • By Samantha C. Shapiro, MD

Updates on ACR Gout Guideline, FDA’s Febuxostat Warning & Pegloticase Therapy

November 19, 2021 • By Jason Liebowitz, MD

Gout Research at a Glance: ‘My picks for the top research in gout presented at ACR Convergence 2021’

November 10, 2021 • By Lisa Stamp, MBChB, PhD

Case Report: Does a Young Woman with Gitelman Syndrome Have Gout?

June 14, 2021 • By Rebecca Lindsey Weiner, DO, & Ann K. Rosenthal, MD, FACP

Pegloticase Safe & Effective for Patients with Gout on Dialysis

May 19, 2021 • By Michele B. Kaufman, PharmD, BCGP

Reducing Immunogenicity of Pegloticase (RECIPE) with Concomitant Use of Mycophenolate Mofetil in Patients with Refractory Gout—a Phase II Double Blind Randomized Controlled Trial

December 10, 2020 • By Puja Khanna, Dinesh Khanna, Gary Cutter, Jeffrey Foster, Joshua Melnick, Sara Jaafar, Stephanie Biggers, AKM Rahman, Hui-Chen Kuo, Michelle Feese and Kenneth Saag

Dr. Ethan Craig Picks His Favorite Gout Abstracts from ACR Convergence 2020

November 19, 2020 • By Keri Losavio

Optimize Gout Management with the Latest Evidence-Based Guidance

November 17, 2020 • By Mary Beth Nierengarten